The Kynurenine Pathway and Neurologic Disease: Therapeutic Strategies

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 125-129

  Heyes, M P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVIA; GERBILLINAE; PRIMATES;

3 HYDROXYANTHRANILIC ACID; 4 CHLORO 3 HYDROXYANTHRANILIC ACID; 4-CHLORO-3-HYDROXYANTHRANILIC ACID; DRUG DERIVATIVE; KYNURENINE; NEUROTOXIN; QUINOLINIC ACID;

ANIMAL; DRUG EFFECT; GERBIL; GUINEA PIG; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIMATE; RAT; REVIEW; SPINAL CORD; SPINAL CORD INJURY;

3-HYDROXYANTHRANILIC ACID; ANIMALS; GERBILLINAE; GUINEA PIGS; HUMANS; KYNURENINE; MACROPHAGE ACTIVATION; MICE; NERVOUS SYSTEM DISEASES; NEUROTOXINS; PRIMATES; QUINOLINIC ACID; RATS; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0030347242     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_20     Document Type: Article

References (23)

1. Bender, D.A., 1982, Biochemistry of tryptophan in health and disease. Molec. Aspects Med. 6: 101.
2. Blight, A.R., 1985, Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent. Nerv. Syst. Trauma 2: 299.
3. Blight, A.R., 1991, Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J. Neurol. Sci. 103: 156.
4. Blight, A.R., 1992, Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9:S83.
5. Blight, A.R., 1993, Remyelination, revascularization and recovery of function in experimental spinal cord injury, in Neural Injury and Regeneration, F. J. Seil, eds, Raven Press, New York, pp. 91-104.
6. Blight, A.R., 1994, Effects of silica on the outcome of experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience 60:263.
7. Blight, A.R., Cohen, T.I., Saito, K. and Heyes, M.P., 1995, Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain In Press, .
8. Blight, A.R., Saito, K. and Heyes, M.P., 1993, Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury. Brain Res. 632:314.
9. Brouwers, P., Heyes, M.P., Moss, H., Wolters, P., El-Amin, D., Poplack, D., Markey, S.P. and Pizzo, P., 1993, Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type-1 disease: relationships to clinical status and therapeutic response. J. Infect. Dis. 168:1380.
10. Giulian, D., Vaca, K. and Noonan, C.A., 1990, Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593.
11. Heyes, M.P., Brew, B.J., Martin, A., Price, R.W., Salazar, A.M., Sidtis, J.J., Yergey, J.A., Mouradian, M.M., Sadler, A.E., Keilp, J., Rubinow, D. and Markey, S.P., 1991, Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurologic status. Ann. Neurol. 29:202.
12. Heyes, M. P., Hutto, B. and Markey, S.P., 1988, 4-chloro-3-hydroxyanthranilic acid inhibits 3-hydroxyanthranilic acid oxidase in brain. Neurochem. Int. 13:405.
13. Heyes, M.P. and Nowak, T.S.J., 1990, Delayed increases in regional brain quinolinic acid follow transient ischemia and the gerbil. J. Cerebral Blood Flow Metabol. 10:660.
14. Heyes, M.P., Saito, K., Crowley, J., Davis, L.E., Demitrak, M.A., Der, M., Dilling, L., Kruesi, M.J.P., Lackner, A., Larsen, S.A., Lee, K., Leonard, H., Markey, S.P., Martin, A., Milstien, S., Mouradian, M.M., Pranzatelli, M.R., Quearry, B.J., Salazar, A., Smith, M., Straus, S.E., Sunderland, T., Swedo, S. and Tourtellotte, W.W., 1992, Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain 115:1249.
15. Heyes, M.P., Saito, K., Major, E.O., Milstein, S., Markey, S.P. and Vickers, J.H., 1993, A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease: Attenuation of synthesis from L-tryptophan by 6-chloro-tryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116:1425.
16. Parli, C.J., Krieter, P. and Schmidt, B., 1980, Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: A potent inhibitor of 3-hydroxyanthranilic acid oxidase. Arch. Biochem. Biophys. 203:161.
17. Saito, K., Chen, C.Y., Masana, M., Crowley, J., Markey, S.P. and Heyes, M.P., 1993a, 4-Chloro-3-hydroxyanthranilic acid, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ stimulated monocytes (THP-1) cells. Biochem. J. 291:11.
18. Saito, K., Crowley, J.S., Markey, S.P. and Heyes, M.P., 1993b, A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268:15496.
19. Saito, K., Markey, S.P. and Heyes, M.P., 1991, Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Research 546:151.
20. Saito, K., Markey, S.P. and Heyes, M.P., 1992, Effects of immune activation on quinolinic acid and kynurenine pathway metabolism in the mouse. Neuroscience 51:25.
21. Saito, K., Markey, S.P. and Heyes, M.P., 1994, 6-Chloro-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci. Lett. 178:211.
22. Saito, K., Nowak, T.S., Jr., Markey, S.P. and Heyes, M.P., 1993c, Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60:180.
23. Stone, T.W., 1993, Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45:309.